Type 2 diabetes: New GLP-1 agonist may lead to long-lasting treatment - Medical News Today
medicalnewstoday.comSubmitted by medicalnewstoday7131 in health
Scientists fused a native GLP-1 with another protein to extend its drug life. This could be a step toward developing a longer-lasting treatment for type 2 diabetes.